BSE: CIPLA - Cipla Limited

Rentabilité sur six mois: -4.8%

Calendrier des promotions Cipla Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments.

plus de détails
It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

ISIN INE059A01026
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.5498
Дивиденд ао 13
Сайт https://www.cipla.com
Цена ао 1438.8
Changement de prix par jour: +0.0035% (1438.8)
Changement de prix par semaine: -3.94% (1497.8)
Changement de prix par mois: -0.5873% (1447.35)
Changement de prix sur 3 mois: -8.44% (1571.45)
Changement de prix sur six mois: -4.8% (1511.35)
Changement de prix par an: +9.61% (1312.75)
Evolution du prix sur 3 ans: +56.13% (921.55)
Evolution du prix sur 5 ans: +209.86% (464.35)
Evolution des prix sur 10 ans: 0% (1438.85)
Evolution des prix depuis le début de l'année: -4.45% (1505.85)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 4.7 3
P/BV 4.46 4
P/E 29.01 6
EV/EBITDA 17.88 6
Total: 6

Efficacité

Nom Signification Grade
ROA, % 13.26 4
ROE, % 16.45 5
Total: 5

Dividendes

Nom Signification Grade
Div yield, % 0.5498 1.38
DSI 1 10
Total: 3.84

Devoir

Nom Signification Grade
Debt/EBITDA 0.0724 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 51.23 7
Rentabilité Ebitda, % 49.05 6
Rentabilité EPS, % 166.18 10
Total: 7.6
Plus de détails

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Raju Sunil Mistry M.A., Ph.D. President & Global Chief People Officer N/A 1965 (60 années)
Mr. Pradeep Bhadauria President & Global Chief Scientific Officer N/A
Mr. Ashish Adukia Global Chief Financial Officer N/A
Mr. Dinesh Ramniranjan Jain Senior VP & Head of Corporate Finance N/A
Mr. Naveen Bansal Head of Investor Relations N/A
Mr. Rajendra Kumar Chopra Compliance Officer & Company Secretary 15.3M
Ms. Heena Kanal Senior Vice-President of Corporate Communications N/A
Mr. Umang Vohra B.E., M.B.A. MD, Global CEO & Executive Director 1971 (54 année)
Ms. Sneha Hiranandani B Com Chief Information Officer
Dr. Jaideep A. Gogtay M.D., Ph.D. Global Chief Medical Officer 1967 (58 années)

Adresse: India, Mumbai, Cipla House - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.cipla.com